Effects of Increased, Egg-Based Protein Intake on Muscle Composition, (S25)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01396915 |
Recruitment Status
:
Completed
First Posted
: July 19, 2011
Last Update Posted
: February 4, 2016
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment |
---|---|
Muscle Composition Sarcopenia Hypertrophy Inflammation | Dietary Supplement: Dietary Protein Intake |
Study Type : | Observational |
Actual Enrollment : | 22 participants |
Observational Model: | Cohort |
Time Perspective: | Retrospective |
Official Title: | Effects of Increased, Egg-Based Protein Intake on Muscle Composition, |
Study Start Date : | February 2011 |
Actual Primary Completion Date : | February 2014 |
Actual Study Completion Date : | February 2014 |

Group/Cohort | Intervention/treatment |
---|---|
High or Normal Dietary Protein Intake |
Dietary Supplement: Dietary Protein Intake
Dietary Protein Intake This is a 12-week randomized,prospective study incorporating a dietary intervention in which subjects will consume either higher protein(HP:1.4g protein•kg-1•d-1) or normal protein diet (NP:.8g protein•kg-1•d-1)
|
- Effects of Increased, Egg-Based Protein Intake on Muscle Composition, Metabolic Health and Systemic Inflammation in Obese, Older Adults [ Time Frame: December 31, 2013 ]Anticipated subject recruitment completion
Biospecimen Retention: Samples With DNA

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 55 Years to 80 Years (Adult, Senior) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- Men and Women between the ages of 55-80
- Body Mass Index between 27-35
- Non Diabetic
- Normal liver, kidney and heart functions within 10% of clinical normalcy
- Not currently following a weight loss or other special /non balanced diets
- weight stable
Exclusion Criteria:
- fasting glucose > 110 mg/dl
- blood pressure > 160/110 mm Hg
- plasma total cholesterol > 260 mg/dl
- LDL-cholesterol >160mg/dl
- triacylglycerol>400 mg/dl
- >than 1 hour/week of habitual aerobic and /or resistance exercise
- Currently taking prescribed blood thinners

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01396915
United States, Indiana | |
Purdue University | |
W. Lafayette, Indiana, United States, 47907 |
Principal Investigator: | Wayne W Campbell, Ph.D. | Purdue University |
Responsible Party: | Wayne Campbell, Wayne Campbell, Ph.D, Purdue University |
ClinicalTrials.gov Identifier: | NCT01396915 History of Changes |
Other Study ID Numbers: |
1101010282 |
First Posted: | July 19, 2011 Key Record Dates |
Last Update Posted: | February 4, 2016 |
Last Verified: | May 2013 |
Keywords provided by Wayne Campbell, Purdue University:
Skeletal muscle lipid content whole muscle volume fasting glucose insulin blood urea nitrogen |
Additional relevant MeSH terms:
Inflammation Sarcopenia Hypertrophy Pathologic Processes Muscular Atrophy Neuromuscular Manifestations |
Neurologic Manifestations Nervous System Diseases Atrophy Pathological Conditions, Anatomical Signs and Symptoms |